Physician

Charles Shane Daniels, MD

According to 2025 Medicare claims, Charles Daniels, MD (NPI: 1710167168) practices pain management in the Wilmington, NC market, with the plurality of this provider's patient population coming from New Hanover, NC. This provider's primary affiliated billing organization is RALEIGH NEUROSURGICAL CLINIC, INC. (NPI: 1598702490; TIN: 560945614) and primary practice location at 28403-6844. Daniels is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Daniels' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 154 traditional Medicare patients, billed 914 HCPCS/CPT codes, and received $132,062 in Medicare payments. The top billing code was 64635 (Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint). Part D data shows 1,254 prescription claims across 257 beneficiaries totaling $46,347 in drug costs, led by Xtampza Er (Oxycodone Myristate). Open Payments data shows 10 records totaling $360. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $135,988 and ending at $46,347. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	162	1,559	$92,453
2016	147	1,327	$84,082
2017	180	1,504	$85,746
2018	172	1,192	$75,206
2019	170	1,248	$84,339
2020	97	1,275	$76,134
2021	107	1,316	$93,497
2022	101	1,285	$81,673
2023	115	861	$82,273
2024	154	914	$132,062

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	203	1,492	$135,988
2016	203	1,392	$127,790
2017	152	872	$60,918
2018	271	1,073	$63,562
2019	337	2,115	$115,304
2020	209	2,449	$111,427
2021	174	2,340	$96,186
2022	182	2,431	$117,270
2023	213	2,073	$243,107
2024	257	1,254	$46,347

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64635	Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint	31	41	$367
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	31	40	$199
64493	Injection of lower or sacral spine facet joint using imaging guidance, single level	31	62	$186
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	106	106	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	116	363	$95

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtampza Er	Oxycodone Myristate	13	390	$11,453
Buprenorphine	Buprenorphine	37	1,015	$7,663
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	179	4,935	$4,546
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	144	4,194	$4,431
Oxycodone Hcl	Oxycodone Hcl	158	4,523	$3,687

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$360	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles Shane Daniels, MD?

Tedicare shows public-source Medicare data for Charles Shane Daniels, MD (NPI 1710167168), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles Shane Daniels, MD have ACO affiliation data?

Charles Shane Daniels, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Charles Shane Daniels, MD?

Charles Shane Daniels, MD is linked to RALEIGH NEUROSURGICAL CLINIC, INC. (billing NPI 1598702490) in the available physician profile data.

Does Charles Shane Daniels, MD have Open Payments data?

Charles Shane Daniels, MD has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.